Please view our latest videos and webinars below on various aspects of obesity science, research, and treatment.
(Three-part video series)
Shirley Hao, MD, of Emory University School of Medicine and Children’s Healthcare of Atlanta discusses how anti-obesity medications have been a game changer for children and teens with obesity in our "Talking Obesity with Experts" video series.
Shirley Hao, MD, of Emory University School of Medicine and Children’s Healthcare of Atlanta discusses how anti-obesity medications have been a game changer for children and teens with obesity. She shares next steps for addressing childhood obesity including the need for lifestyle changes and a cultural shift in our next "Talking Obesity with Experts" video series.
Shirley Hao, MD, of Emory University School of Medicine and Children’s Healthcare of Atlanta discusses how anti-obesity medications have been a game changer for children and teens with obesity. She expounds on prescribing habits and safety in our "Talking Obesity with Experts" video series.
(Four-Part Video Series)
Daniel Drucker, MD, recent winner of our Lifetime Achievement Laureate Award, the top honors in the field, shares his story as one of the first researchers to discover GLP-1s for treating diabetes and obesity. He describes the discovery as a team effort and looks forward to future research developments in obesity care.
Video 1: Talking Obesity with Daniel Drucker: Story of A Pioneer in Obesity Care
The Changing Landscape of Obesity Care—An Endocrine Society Virtual Science Writers Conference (February 2023)
Obesity | ENDO 2022 Press Conference
ENDO 2022 Research Highlight: New Findings in Anti-Obesity Medications
Obesity In America: What You Need to Know About the Impact of COVID-19, Disparities, and Policy Options. (June 2021)
Read our “Obesity Playbook," updated April 2025. This educational resource on obesity and health is designed for Congressional staff, covering the latest facts and figures, the state of science, and policy options.
Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities.